Thymus- and Spleen-Derived Immunosuppressive Peptides

  • I. Blazsek
  • G. Mathé
  • M. Lenfant
  • N. Kiger
Part of the GWUMC Department of Biochemistry Annual Spring Symposia book series (GWUN)


The hematoimmunological machinery appears to be regulated by soluble factors acting in two opposite directions, those of subpopulation size and function amplification and reduction (suppression), respectively (Table I).


Immunosuppressive Factor Minor Histocompatibility Antigen Bone Marrow Graft Spleen Index Subpopulation Size 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bach, J.-F., Bach, A.-M., Blanot, D., Bricas, E., Charreire, J., Dardenne, M., Fournier, C., and Pléau, J. M., 1978, Facteur thymique sêrique (FTS), Bull. Inst. Pasteur 76:325.Google Scholar
  2. Blazsek, I., and Gaal, D., 1978, Endogenous thymic factors regulating cell proliferation and analysis of their mechanism of action, Cell Tissue Kinet. 11:265.PubMedGoogle Scholar
  3. Dardenne, M., Pléau, J. M., Man, N. K., and Bach, J.-F., 1977, Structural study of circulating thymic factor: A peptide isolated from pig serum, J. Biol. Chem. 252:8040.PubMedGoogle Scholar
  4. Fridman, W. M, Guimezanes, A., and Gisler, R. H., 1977, Characterization of suppressive immunoglobulin binding factor (IBF). I. Production of IBF by a O positive lymphone (L 5178-Y), J. Immunol. 119:1266.PubMedGoogle Scholar
  5. Garcia-Giralt, E., Lenfant, M., Privat De Garilhe, M., Mayadoux, E., and Motta, R., 1978, Purification of immunosuppressive factors extracted from bovine spleen. II. Biological activity, Cell Tissue Kinet. 11:465.PubMedGoogle Scholar
  6. Goldstein, A. L., Low, T. L. K., Thurman, G. B., Zatz, M. M., Hale, N., Chen, J. Hu, S. K., Naylor, P. B., and McClure, G. E., et al., 1981, Current status of thymosin and other hormones of the thymus gland, Recent Prog. Horm. Res. 37:369.PubMedGoogle Scholar
  7. Grundboeck Jusko, J., 1976, Chemical characteristics of chalones isolated from bovine spleen, Acta Biochim. Pol. 23:165.PubMedGoogle Scholar
  8. Kiger, N., Florentin, I., Lorans, G., and Mathe, G., 1977, Further purification and chemical characterization of the lymphocyte inhibitory factor extracted from thymus, Immunology 33:439.PubMedGoogle Scholar
  9. Lee, S. T., and Paraskevas, F., 1977, Soluble factors in mouse immune sera. III. Origin, Nature and target of small molecular weight suppressive factors isolated from serum during primary responses, Cell. Immunol. 32:171.CrossRefGoogle Scholar
  10. Lenfant, M., and Millerioux-Di Giusto, L., 1982, New insight into lymphocytic chalone research: The ‘facteur thymique serique’ (FTS) might be responsible for part of the immunosuppressive activity detected in the ‘chalone fraction,’ Int. Arch. Allergy Appl. Immunol. 68:387.PubMedCrossRefGoogle Scholar
  11. Lenfant, M., Privat De Garilhe, M., Garcia-Giralt, E., and Tempete, C., 1976, Further purification of bovine spleen inhibitors of lymphocyte DNA synthesis, Biochim. Biophys. Acta 451:106.PubMedCrossRefGoogle Scholar
  12. Lenfant, M., Garcia-Giralt, E., Thomas, M., and Di Giusto, L., 1978, Purification of immunosuppressive factors extracted from bovine spleen (lymphoid chalone). I, Cell Tissue Kinet. 11:455.PubMedGoogle Scholar
  13. Lenfant, M., Garcia-Giralt, E., Di Giusto, L., and Thomas, M., 1980, The purification of an immunosuppressive factor extracted from bovine spleen. III. Purification process, Mol. Immunol. 17:119.PubMedCrossRefGoogle Scholar
  14. Lenfant, M., Millerioux-Di Giusto, L., Masson, A., and Gasc, J. C., 1981a, Shortened purification procedure of a spleen derived immunosuppressive peptide, J. Chromatogr. 20b:177.Google Scholar
  15. Lenfant, M., Millerioux, L., Duchange, N., and Tanzer, J., 1981b, De la recherche d’une chalone lymphocytaire du facteur thymique sérique, C. R. Acad. Sci. 292:403.Google Scholar
  16. Mathé, G., 1972, Lymphocyte inhibitors fulfilling the definition of chalones and immunosuppression, Rev. Eur. Etudes Clin. Biol. 17:548.Google Scholar
  17. Mathé, G., Pritchard, L. L., and Halle-Pannenko, O., 1979, Mismatching for minor transplantation antigens in bone marrow transplantation: Consequence for the development and control of severe graft-versus-host disease, Transplant. Proc. 11:235.PubMedGoogle Scholar
  18. Maurer, H. R., and Laerum, O. D., 1976, Granulocyte chalone testing, a critical review, in: Chalones (J. C. Houck, ed.), p. 331, North-Holland, Amsterdam.Google Scholar
  19. Millerioux, L., Duchange, N., Masson, A., and Lenfant, M., 1981, Relation between a spleen derived immunosuppressive peptide and the immunoglobulin binding factor, Cell. Immunol. 44:249.Google Scholar
  20. Namba, Y., Jegasothy, B. V., and Waksman, B. H., 1977, Regulatory substances produced by lymphocytes. V. Production of inhibitor DNA synthesis (IDS) by proliferating T lymphocytes, J. Immunol. 118:1379. New York Academy of Sciences Conference on Tuftsin, 1983, in press.PubMedGoogle Scholar
  21. Nordland, K., Sandberg, G., and Thyberg, J., 1979, Further studies on splenic material inhibiting the growth of lymphocytes in vitro, Int. Arch. Allergy Appl. Immunol. 60:195.CrossRefGoogle Scholar
  22. Nozaki et al., 1977, Bull. Chem. Soc. Jpn. 50: 422. Cited in Serva, Fine Chemicals for the Scientist, 1983/84, p. 357.CrossRefGoogle Scholar
  23. Pléau, J. M., Dardenne, M., Blouquit, Y., and Bach, J.-F., 1977, Structural study of circulating thymic factor: A peptide isolated from pig serum. II. Amino-acid sequence, J. Biol. Chem. 252:8045.PubMedGoogle Scholar
  24. Rappaport, H., Khalil, A., Halle-Pannenko, O., Pritchard, L. L., Dantchev, D., and Mathe, G., 1979, Histopathologic sequence of events in adult mice undergoing lethal graft-versus-host reaction developed across H-2 and/or non H-2 and/or H-2 histocompatibility barriers, Am. J. Pathol. 96:121.PubMedGoogle Scholar
  25. Susuki, S., and Huchet, R., 1982, Properties of histamine-induced suppressor factor in the regulation of lymphocyte response to PHA in mice, Cell. Immunol. 68:349.CrossRefGoogle Scholar
  26. Tadakuma, T., Kuhner, A. L., Rich, R. R., David, J. R., and Pierce, C. W., 1976, Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells, J. Immunol. 117:323.PubMedGoogle Scholar
  27. Voorting-Hawkins, M., and Michael, G., 1977, Isolation and characterization of immunoregulatory factors from normal human serum. I. Preliminary biochemical and biological characterization of immunosuppressive factors, J. Immunol. 118:505.Google Scholar
  28. Wang, B. F., Badger, A. M., Nimberg, R. R., Cooperband, S. R., Schmid, K., and Mannick, J. A., 1977, Suppression of tumor specific cell mediated cytotoxicity by immunoregulatory alpha globulinlike peptides from cancer patients, Cancer Res. 37:3022.PubMedGoogle Scholar
  29. Ward, K., and Munro, A. J., 1979, Non-specific immunosuppressive effects of mouse spleen extracts in vitro, Immunology 37:61.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • I. Blazsek
    • 1
  • G. Mathé
    • 1
  • M. Lenfant
    • 1
  • N. Kiger
    • 1
  1. 1.Institut de Cancérologie et d’Immunogénétique (INSERM U-50)Hôpital Paul-BrousseVillejuifFrance

Personalised recommendations